2022 Deal-Making Snapshot: One Big Deal Didn’t Change The Downward Trends

Amgen/Horizon Buyout Lessened Decline

 
• By Joseph Haas
  
business documents accounting with calculator and magnifying glass. concept for financial
2022 saw a significant decline in biopharma M&A activity
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business